Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

Clinical trial NCT03475212 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03475212
Sponsor: Pediatric Transplantation & Cellular Therapy Consortium
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus Infections Adenovirus Infection EBV Infection

Start date: 2018-06-20
Primary completion: 2025-06-30
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.